INTRODUCTION
============

Major depressive disorder (MDD) and coronary heart disease (CHD) are leading burdens of disease and the relationship between these disorders is bidirectional ([@B21]; [@B23]; [@B30]; [@B18]): many patients experience depression decades before CHD is manifest, while MDD in patients with CHD is associated with increased morbidity and mortality. However, it remains unclear whether MDD, anxiety disorder or their comorbidity are most associated with CHD. Research has begun to highlight associations between the anxiety disorders and CHD ([@B31]; [@B32]). A study on participants recruited for the Netherlands Study of Depression and Anxiety (*N* = 2807) reported that persons with current anxiety disorders with or without depression have a threefold increased prevalence of CHD, while no associations were observed for those with depressive disorders alone, or for depressive and anxiety disorders in remission ([@B33]). Research has been restricted to high-income countries including Australia, Canada, Denmark, Finland, Netherlands, UK, and USA ([@B33]; [@B31]), highlighting a need for research in low to middle-income countries. Given the lack of data on the associations between common mental disorders (CMD), specific mood and anxiety disorders, and CHD in Brazil, an upper-middle-income country, the present study sought to address this need.

It is unclear whether the associations between the mood and anxiety disorders, and CHD parallel those or differ from the findings reported in developed countries such as the Netherlands (e.g., [@B33]). Research has demonstrated that Brazil is characterized by higher rates of mental disorders ([@B1]), while rates of antidepressant use ([@B3]) are lower than high-income countries. Brazil faces significant social challenges that may contribute to psychological distress ([@B8]), which may affect observed associations. For example, Brazil has one of the highest levels of income inequality in the world and recent data from this country ([@B11]) indicate that this inequality is associated with mental disorders, especially depression. The authors argued that inequality is associated with adverse social comparisons, leading to psychological distress, and increases in disease and mortality, consistent with the 'relative income hypothesis' ([@B35]). Income inequality is likely one of many psychosocial stressors that may affect the associations between the mood and anxiety disorders and CHD in Brazil. We hypothesized a relationship between CMD and CHD, and predicted that the prevalence of CHD would be most robust in those with comorbid MDD and anxiety disorders after controlling for relevant confounding factors including antidepressant medications, socio-demographic issues, physical inactivity, obesity and smoking, as well as risk factors including dyslipidemia, hypertension, and diabetes. Here we defined CHD as participants reporting a medical history of stable angina pectoris, myocardial infarction (MI) or coronary revascularisation.

MATERIALS AND METHODS {#s1}
=====================

PARTICIPANTS
------------

ELSA-Brasil is a cohort of 15,105 civil servants aged 35 to 74 enrolled between August, 2008 and December, 2010 at six cities (Belo Horizonte, Porto Alegre, Rio de Janeiro, Salvador, Sao Paulo, and Vitoria) designed to investigate the relationship between cardiovascular diseases and diabetes, their social determinants and risk factors. The study design and sampling procedures of ELSA-Brasil have been reported previously ([@B2]; [@B27]). Exclusion criteria comprised current or recent pregnancy (within 4 months of first interview), intention to quit working at the institution in the near future, severe cognitive or communication impairment, and if retired, residence outside of a study centre's metropolitan area.

ETHICS STATEMENT
----------------

The ethics committees of the participating universities approved the research protocol. All participants provided written informed consent after a complete description of the study. The study design and sampling procedures of ELSA-Brasil have been reported previously ([@B2]; [@B27]).

PSYCHIATRIC EVALUATION
----------------------

Mental disorders were determined by trained interviewers using the Portuguese version ([@B22]) of the Clinical Interview Schedule-Revised (CIS-R; [@B17]). This is a structured interview used for diagnosis of current, common, non-psychotic psychiatric conditions in the community. The complete CIS-R version was applied; CMDs were defined as participants with CIS-R scores ≥12. The following ICD-10 categories were also determined: MDD, agoraphobia, social phobia, specific phobia, generalized anxiety disorder (GAD), panic disorder, social anxiety disorder, and mixed anxiety and depressive disorder (MADD). The ICD-10 refers to the 10th revision of the International Statistical Classification of Diseases and Related Health Problems, a medical classification list by the World Health Organization. These diagnostic groupings were then reduced to six categories: MDD, GAD, all phobias, panic disorder, a comorbid group comprised of participants with MDD and any anxiety disorder, and MADD. The latter two categories are distinct; the former comprises participants that meet criteria for both MDD and any anxiety disorder, while the latter comprises participants who display symptoms of both anxiety and depression, but do not meet the criteria of either diagnosis separately.

CORONARY HEART DISEASE ASSESSMENT
---------------------------------

Coronary heart disease included participants who reported a medical diagnosis of stable angina pectoris, MI or coronary revascularization determined through questionnaire- and intensive interview-based assessment focusing on medical history.

COVARIATES
----------

Sociodemographic information included age, sex, years of education (less than high-school, high-school, university) and race (white, mixed, black, Asiatic, indigenous). Lifestyle and behavioral characteristics included smoking status (never, past/current), physical activity (measured with the International Physical Activity Questionnaire ([@B6]) and categorized according to low, moderate, or high activity based on scoring guidelines: <http://www.ipaq.ki.se/scoring.pdf>) and body mass index (BMI; weight in kilograms divided by height in meters squared). Established risk factors for CHD were also considered in analysis; these included hypertension, diabetes mellitus (DM), and dyslipidemia. Hypertension was defined as systolic blood pressure ≥140 mm Hg, or diastolic blood pressure ≥90 mm Hg, or use of antihypertensive medications. Resting blood pressure was measured three times in the seated position after 5 min rest, and the average of the second and third measurements were used in analyses. Diabetes was defined as self-reported or fasting blood glucose ≥126 mg/dL or 2-h oral glucose tolerance test ≥200 mg/dL or glycated hemoglobin ≥6.5%. Dyslipidemia was defined as LDL-cholesterol ≥130 mg/dL or use of lipid reductor. We identified antihypertensive treatments, medications for diabetes, and antidepressants on the basis of prescription and over-the-counter drugs in the past 2 weeks determined through pill bottle review. Antidepressant use was added as a covariate considering that antidepressant medications may also contribute to morbidity and mortality ([@B29]; [@B34]; [@B12]).

STATISTICAL ANALYSIS
--------------------

Statistical analysis was conducted using IBM SPSS Statistics Version 21. Participant characteristics were examined using independent samples *t*-tests and one-way analyses of variance (ANOVA) for contrasts involving continuous dependent measures, and χ^2^ statistics for categorical variables. Tukey's HSD was used to correct for multiple comparisons and aid interpretation of ANOVA's, while standardized residuals (*z*-scores) were used to help interpret chi-square tests on larger contingency tables (as per [@B10]). A series of logistic regression analyses were then used to estimate the odds ratios and 95% confidence intervals for the association between CMD and CHD, before and after adjustment for covariates. These initial analyses were followed up by sensitivity analysis on the specific mental disorder groupings. Unadjusted analyses (Model 1) were conducted on CMD, as well as specific mental disorder groupings, with no other predictors. Adjusted multivariate analyses (Model 2) involved hierarchical (blockwise) logistic regression analysis on *a priori* selected covariates (as described in previous section). Each covariate grouping (i.e., sociodemographic information, lifestyle/behavioral characteristics, risk factors, and medications) was entered into a successive block; mental disorders were entered into the final block. Variables in each block were entered simultaneously using the forced entry method to assess the independent contribution of each predictor over and above all other predictors entered in the same block. Finally, additional sensitivity analyses were conducted for subtypes of CHD including stable angina pectoris, MI, and coronary revascularisation to determine the consistency of associations across these distinct categories of CHD. Again, these analyses involved hierarchical (blockwise) logistic regression analysis adjusting for covariate groupings (as per Model 2).

RESULTS
=======

PARTICIPANT CHARACTERISTICS
---------------------------

**Table [1](#T1){ref-type="table"}** summarizes participant characteristics by CHD status. Compared to participants without CHD (*n* = 14,366), those with CHD (*n* = 721) were older, black, less educated, and male. They engaged in less physical activity, were heavier, more likely to have smoked (or to be a smoker), have DM, hypertension, dyslipidemia, or a CMD and to be medicated with antidepressants. When groupings of mental disorders were examined, comorbid MDD and anxiety was significantly associated with CHD. **Table [2](#T2){ref-type="table"}** presents participant characteristics according to whether or not participants were identified as having a CMD. Compared to those without CMD (*n* = 11,058), participants with CMD (*n* = 4,036) were more likely to be younger, less educated, and female. They were less likely to be white, engaged in less physical activity, and were heavier. They were more likely to have smoked (or to be a smoker), to have DM or CHD, and to be medicated with antidepressants. **Table [3](#T3){ref-type="table"}** provides finer grained detail on participant characteristics by specific mental disorder groupings including MDD (*n* = 179), GAD (*n* = 1,458), phobias (*n* = 156), PD (*n* = 74), MADD (*n* = 1914), comorbid MDD, and anxiety disorders (*n* = 451) as well as controls.

###### 

Participant characteristics by coronary heart disease (CHD) status^1^.

  ---------------------------------------------------------------------------------------------------------------------------
  Characteristics                        No CHD (*n* = 14366, 93%)   CHD (*n* = 721, 7%)   Statistic
  -------------------------------------- --------------------------- --------------------- ----------------------------------
  Age, mean (SD)                         51.75 (8.97)                58.71 (8.75)          *t*(15085) = 20.34, *p* \< 0.001

  Women (%)                              54.9                        45.5                  χ^2^(1) = 24.28, *p* \< 0.001

  Education (%)                                                                            χ^2^(2) = 85.03, *p* \< 0.001

     Less than high-school\              12.1\                       23.6\                 
     High-school\                        34.7\                       33.6\                 
     College                             53.2                        42.9                  

  Race (%)                                                                                 χ^2^(4) = 7.76, *p* = 0.101

     White\                              52.4\                       50.1\                 
     Mixed\                              28.2\                       27.1\                 
     Black\                              15.9\                       19.2\                 
     Asiatic\                            2.5\                        2.1\                  
     Indigenous                          1.0                         1.6                   

  Smoker (past or current) (%)           42.5                        55.9                  χ^2^(1) = 50.39, *p* \< 0.001

  Physical activity                                                                        χ^2^(2) = 8.59, *p* = 0.014

     Low\                                76.9\                       77.7\                 
     Moderate\                           13.9\                       16.0\                 
     High                                9.2                         6.3                   

  Body mass index (kg/m^2^), mean (SD)   26.95 (4.74)                28.40 (4.82)          *t*(15079) = 7.99, *p* \< 0.001

  Antidepressant status (yes) (%)        6.0                         8.7                   χ^2^(1) = 8.39, *p* = 0.004

  Diabetes mellitus (DM; yes) (%)        18.8                        37.7                  χ^2^(1) = 156.38, *p* \< 0.001

  Hypertension (yes) (%)                 34.0                        70.0                  χ^2^(1) = 384.40, *p* \< 0.001

  Dyslipidemia (yes) (%)                 56.9                        75.9                  χ^2^(1) = 101.50, *p* \< 0.001

  Mental disorder status (%)                                                               χ^2^(1) = 28.04, *p* \< 0.001

     No mental disorder\                 73.7\                       64.8\                 
     Common mental disorder (CMD)        26.3                        35.2                  

  Mental disorder groupings^2^ (%)                                                         χ^2^(1) = 20.05, *p* = 0.003

     MDD\                                1.2\                        2.0\                  
     GAD\                                9.9\                        10.2\                 
     Phobias\                            1.0\                        1.5\                  
     PDMADD\                             0.5\                        0.7\                  
     Comorbid                            13.0\                       14.6\                 
                                         2.9                         6.6                   
  ---------------------------------------------------------------------------------------------------------------------------

1

Some proportions might not add up to due to rounding, and small numbers of participants with missing data.

2

Participants categorized into major depressive disorder (MDD), generalized anxiety disorder (GAD), and panic disorder (PD) did not have additional comorbidity. The Phobias category includes Agoraphobia with or without panic disorder, Social Phobias and Specific Phobias. mixed anxiety and depressive disorder (MADD) includes participants who display symptoms of both anxiety and depression, but do not meet the criteria of either diagnosis separately, while the Comorbid group (comorbid anxiety and depression) includes participants that meet criteria for MDD and any anxiety disorder.

###### 

Participant characteristics by CMD status^1^.

  -------------------------------------------------------------------------------------------------------------------------------
  Characteristics                        No CMD (*n* = 11058, 73%)   CMD (*n* = 4036, 27%)   *p*-value
  -------------------------------------- --------------------------- ----------------------- ------------------------------------
  Age, mean (SD)                         52.60 (9.22)                50.70 (8.53)            *t*(7703.15) = 11.85, *p* \< 0.001

  Women (%)                              49.2                        68.7                    \(1\) = 451.06, *p* \< 0.001

  Education (%)                                                                              \(2\) = 160.27, *p* \< 0.001

     Less than high-school\              12.3\                       14.0\                   
     High-school\                        32.0\                       41.7\                   
     College                             55.7                        44.3                    

  Race (%)                                                                                   \(4\) = 133.98, *p* \< 0.001

     White\                              54.7\                       45.3\                   
     Mixed\                              26.6\                       32.4\                   
     Black\                              15.0\                       19.1\                   
     Asiatic\                            2.8\                        1.8\                    
     Indigenous                          0.9                         1.4                     

  Smoker (past or current) (%)           42.3                        45.2                    \(1\) = 10.26, *p* \< 0.001

  Physical activity                                                                          \(2\) = 164.39, *p* \< 0.001

     Low\                                74.4\                       84.1\                   
     Moderate\                           15.3\                       10.3\                   
     High                                10.4                        5.5                     

  Body mass index (kg/m^2^), mean (SD)   26.84 (4.61)                27.58 (5.08)            *t*(6602.94) = 8.31, *p* \< 0.001

  Antidepressant status (yes) (%)        4.6                         10.5                    \(1\) = 180.53, *p* \< 0.001

  DM (yes) (%)                           19.1                        21.2                    \(1\) = 8.078, *p* = 0.004

  Hypertension (yes) (%)                 35.7                        36.0                    \(1\) = 0.082, p = 0.775

  Dyslipidemia (yes) (%)                 58.3                        56.4                    \(1\) = 4.64, *p* = 0.031

  CHD status (%)                                                                             \(1\) = 28.04, *p* \< 0.001

     No\                                 95.8\                       93.7\                   
     Yes                                 4.2                         6.3                     
  -------------------------------------------------------------------------------------------------------------------------------

1

Some proportions might not add up to 100 due to rounding, and small numbers of participants with missing data.

###### 

Participant characteristics by mental disorder groupings^1,2^.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Characteristics                CTL (*n* = 10412)   MDD (*n* = 179)   Phobias (*n* = 156)   PD (*n* = 74)   GAD (*n* = 1458)   MADD (*n* = 1914)   Comorbid (*n* = 451)   *p*-value
  ------------------------------ ------------------- ----------------- --------------------- --------------- ------------------ ------------------- ---------------------- ------------------------------------
  Age, mean (SD)                 52.66 (9.23)        50.87 (8.99)      50.15\* (8.40)        52.69 (8.48)    50.92\* (8.50)     50.72\* (8.71)      51.25\* (8.44)         *F*(6,14650) = 20.58, *p* \< 0.001

  Women (%)                      48.4\*              74.9\*            53.5                  66.2            69.6\*             66.4\*              75.1\*                 χ^2^(6) = 508.12, *p* \< 0.001

  Education (%)                                                                                                                                                            χ^2^(12) = 165.07, *p* \< 0.001

     Less than high-school\      12.4\               14.0\             17.8\                 24.3\*\         12.3\              12.7\               16.3\*\                
     High-school\                31.8\*\             37.4\             45.9\*\               44.6\           39.4\*\            38.8\*\             48.5\*\                
     College                     55.8\*              48.6              36.3\*                31.1\*          48.3\*             48.6\*              35.2\*                 

  Race (%)                                                                                                                                                                 χ^2^(24) = 160.13, *p* \< 0.001

     White\                      54.8\*\             55.1\             43.5\                 25.7\*\         49.9\              44.5\*\             41.6\*\                
     Mixed\                      26.6\*\             27.0\             33.1\                 36.5\           29.5\              32.9\*\             35.4\*\                
     Black\                      14.9\*\             14.6\             22.7\*\               33.8\*\         16.7\              19.6\*\             19.2\                  
     Asiatic\                    2.7 0.9             2.8\              0\*\                  2.7\            2.6\               1.9 1.2             1.5\                   
     Indigenous                                      0.6               0.6                   1.4             1.3                                    2.2\*                  

  Smoker (past or current), %    42.2                50.8              45.2                  52.7            44.4               42.9                49.6\*                 χ^2^(12) = 19.35, *p* = 0.004

  Physical activity                                                                                                                                                        χ^2^(12) = 149.18, *p* \< 0.001

     Low\                        74.3\*\             85.1\             85.3\                 78.1\           80.1\              83.8\*\             88.6\*\                
     Moderate\                   15.3\*\             9.1\              9.6\                  15.1\           12.6\              10.3\*\             7.6\*\                 
     High                        10.4\*              5.7               5.1                   6.8             7.3\*              6.0\*               3.8\*                  

  BMI (kg/m^2^), mean (SD)       26.81 (4.58)        27.90\* (5.11)    27.71 (5.34)          27.01 (4.71)    27.36\* (5.03)     27.48\* (5.03)      27.93\* (5.32)         *F*(6,14644) = 12.17, *p* \< 0.001

  Hypertension (yes) (%)         35.7                34.6              38.9                  47.3            36.6               35.0                36.6                   χ^2^(6) = 6.07, *p* = 0.42

  Diabetes (yes) (%)             19.0                22.9              24.2                  29.7\*          18.8               21.3                22.9                   χ2(6) = 17.57, *p* = 0.007

  Dyslipidemia (yes) (%)         58.5                53.7              53.8                  60.8            57.2               56.4                55.8                   χ^2^(6) = 6.89, *p* = 0.331

  Antidepressant Use (yes) (%)   4.4\*               13.6\*            8.9                   9.5             10.9\*             7.3\*               15.8\*                 χ^2^(6) = 217.86, *p* \< 0.001

  CHD (yes) (%)                  4.3\*               7.8               6.4                   6.8             4.8                5.2                 10.0\*                 χ^2^(6) = 39.47, *p* \< 0.001
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

1

Some proportions might not add up to 100% due to rounding, and small numbers of participants with missing data. \*Refers to one-way ANOVA in which disorder is compared to controls (Tukey's HSD,

p

\< 0.05) or standardized residuals (

z

-scores) from χ

2

statistics lying outside ±1.96 reflecting a significance of value of

p

\< 0.05.

ASSOCIATION BETWEEN MENTAL DISORDERS AND CHD
--------------------------------------------

**Table [4](#T4){ref-type="table"}** describes the results of unadjusted and fully adjusted logistic regression analyses assessing the association of CMD as well as mental disorder groupings relative to those without mental disorders. Model 1 provides the results of unadjusted analyses conducted for CMD \[model χ^2^(1) = 26.53, *p* = 0.001\] and specific mental disorder groupings \[model χ^2^(6) = 32.16, *p* \< 0.001\]. Model 2 refers to adjusted analyses for CMD \[model χ^2^ (17) = 708.25, *p* \< 0.001; block χ^2^ (1) = 43.76, *p* \< 0.001\] and mental disorder groupings \[model χ^2^ (22) = 686.87, *p* \< 0.001; block χ^2^ (6) = 43.06, *p* \< 0.001\]. In the fully adjusted model (model 2), the odds of CHD were most robust for those with comorbid MDD and anxiety disorders (OR: 2.99, 95% CI = 2.10--4.28), followed by those participants with MDD (OR: 2.14, 95% CI = 1.17--3.95), participants with GAD (OR: 1.41, 95% CI = 1.07--1.85), and participants that displayed symptoms of both anxiety and depression, but did not meet the criteria of either diagnosis separately (MADD; OR: 1.53, 95% CI = 1.20--1.94). Participants with comorbid MDD and anxiety disorders display a greater association with CHD, than GAD and MADD (i.e., confidence intervals do not overlap), but not MDD.

###### 

Unadjusted (model 1) and adjusted (model 2) associations of mental disorders with CHD.

                                     CHD: model 1^a^ (*n* = 721)   CHD: model 2^b^ (*n* = 721)                                                           
  ---------------------------------- ----------------------------- ----------------------------- -------------- --------- ------- ------- -------------- ---------
  **Common mental disorder (CMD)**                                                                                                                       
  No CMD                             11050                                                       REF                      10631           REF            
  CMD                                4026                          1.526                         1.304--1.787   \<0.001   3869    1.829   1.535--2.179   \<0.001
  **Mental disorder groupings**                                                                                                                          
  No mental disorder                 10405                                                       REF                      10012           REF            
  MDD                                179                           1.908                         1.097--3.320   0.022     170     2.144   1.165--3.945   0.014
  Phobias                            156                           1.540                         0.806--2.944   0.191     151     1.555   0.763--3.169   0.224
  PD                                 74                            1.630                         0.654--4.059   0.845     73      1.433   0.553--3.708   0.459
  GAD                                1457                          1.135                         0.877--1.469   0.337     1394    1.405   1.068--1.849   0.015
  MADD                               1914                          1.240                         0.992--1.549   0.059     1844    1.528   1.203--1.941   0.001
  Comorbid                           451                           2.492                         1.806--3.440   \<0.001   434     2.994   2.096--4.275   \<0.001

a

Model 1 relates to separate unadjusted analyses for CMD and specific mental disorder groupings including MDD, Phobias, panic disorder (PD), generalized anxiety disorder (GAD), mixed anxiety and depressive disorder (MADD), and Comorbid MDD and any anxiety disorder.

b

Model 2 relates to analyses adjusted for sociodemographic variables (age, sex, years of education, ethnicity), lifestyle and behavioral characteristics (smoking status, physical activity, body mass index), risk factors (hypertension, diabetes, dyslipidemia), and medications for lipid reduction, hypertension, diabetes, and mental disorders (antidepressants).

ASSOCIATION BETWEEN MENTAL DISORDERS AND CHD SUBTYPES
-----------------------------------------------------

**Table [5](#T5){ref-type="table"}** reports results for additional sensitivity analyses on stable angina pectoris, MI, and coronary revascularization.

###### 

Association between mental disorders and CHD subtypes fully adjusted for sociodemographic variables, lifestyle and behavioral characteristics, risk factors, and medications.

                                     Angina (*n* = 305)   Myocardial infarction (MI) (*n* = 259)   Coronary revascularisation (*n* = 239)                                                                                     
  ---------------------------------- -------------------- ---------------------------------------- ---------------------------------------- --------- ------- ------- -------------- --------- ------- ------- -------------- ---------
  **Common mental disorder (CMD)**                                                                                                                                                                                            
  No CMD                             10358                                                         REF                                                10634                          REF       10635                          REF
  CMD                                3755                 2.134                                    1.671--2.724                             \<0.001   3877    1.615   1.213--2.151   0.001     3878    1.431   1.048--1.954   0.024
  **Mental disorder groupings**                                                                                                                                                                                               
  No mental disorder                 9754                                                          REF                                                10014                          REF       10015           REF            
  MDD                                165                  2.866                                    1.359--6.043                             0.006     170     2.142   0.818--5.611   0.121     170     0.427   0.057--3.215   0.408
  Phobias                            146                  1.616                                    0.585--4.469                             0.355     152     2.191   0.843--5.696   0.107     152     0.470   0.063--3.490   0.461
  PD                                 71                   2.117                                    0.648--6.914                             0.214     73      0.615   0.081--4.653   0.637     73      1.691   0.381--7.503   0.489
  GAD                                1362                 1.588                                    1.092--2.310                             0.015     1395    1.219   0.759--1.957   0.413     1395    1.330   0.818--2.162   0.250
  MADD                               1795                 1.639                                    1.175--2.286                             0.004     1847    1.536   1.045--2.255   0.029     1847    1.447   0.951--2.201   0.084
  Comorbid                           412                  2.976                                    1.831--4.834                             \<0.001   436     3.051   1.743--5.342   \>0.001   436     3.087   1.668--5.713   \<0.001

For angina, there was a significant association with CMD \[model χ^2^(17) = 199.51, *p* \< 0.001; block χ^2^(1) = 35.49, *p* \< 0.001\], and mental disorder groupings \[model χ^2^(22) = 189.43, *p* \< 0.001; block χ^2^(6) = 27.57, *p* \< 0.001\] after full adjustment. Results indicate that MDD, GAD, MADD, and comorbid MDD and anxiety disorders are associated with angina; odds were most robust for the comorbid group (OR: 2.98, 95% CI = 1.83--4.83), followed by MDD (OR: 2.87, 95% CI = 1.36--6.04), GAD (OR: 1.58, 95% CI = 1.09--2.31), and MADD (OR: 1.64, 95% CI = 1.18--2.29). It should be noted that confidence intervals are overlapping for each of these groups, so we cannot say with certainty that one group displays a 'greater' association with CHD over another.

For MI, there was a significant association with CMD \[model χ^2^(17) = 447.07, *p* \< 0.001; block χ^2^(1) = 10.32, *p* \< 0.001), and mental disorder groupings \[model χ^2^(22) = 442.72, *p* \< 0.001; block χ^2^(6) = 18.41, *p* = 0.005\] after full adjustment. Results indicate that MADD and Comorbid groupings are associated with MI; odds were most robust for the Comorbid group (OR: 3.051, 95% CI = 1.74--5.34) followed by the MADD group (OR: 1.54, 95% CI = 1.05--2.26). Again, confidence intervals are overlapping for Comorbid and MADD groupings, thus we cannot say that the Comorbid group displays a 'greater' association with MI, than MADD. For coronary revascularisation, there was a significant association with CMD \[model χ^2^(17) = 483.15, *p* \< 0.001; block χ^2^(1) = 4.88, *p* = 0.027\], and mental disorder groupings \[model χ^2^(22) = 479.79, *p* \< 0.001; block χ^2^(6) = 15.01, *p* = 0.02\] after full adjustment. Results indicate that the Comorbid group only is associated with coronary revascularisation (OR: 3.087, 95% CI = 1.67--5.71)

DISCUSSION
==========

The goal of this study was to determine the associations between CMD, specific mood and anxiety disorder groupings, and CHD in a large cohort of participants recruited for the ELSA-Brasil project. Major findings highlight a significant association between CMD and CHD (OR: 1.83, 95% CI = 1.53--2.18), even after full adjustment for sociodemographic variables, lifestyle and behavioral characteristics, and additional risk factors including dyslipidemia, hypertension, diabetes, and medication use. Further analysis revealed that this association is most apparent in MDD, GAD, MADD and comorbid MDD, and anxiety. No significant associations were observed for phobias or PD. The association was most robust for those with comorbid MDD and anxiety (OR: 2.99, 95% CI = 2.10--4.28), followed by MDD (OR: 2.14, 95% CI = 1.17--3.95), MADD (OR: 1.53, 95% CI = 1.1.20--1.94), and GAD (OR: 1.41, 95% CI = 1.07--1.85). Notably, participants with comorbid MDD and anxiety disorders display a greater association with CHD, than GAD and MADD, but not MDD, a specific finding that we discuss further below. Examination of CHD subtypes also revealed important information; while MDD, GAD, MADD and comorbid MDD, and anxiety were associated with a significant increase in odds for angina, only those with comorbid MDD and anxiety disorders and MADD displayed an increase in odds for MI and coronary revascularisation. In summary, findings highlight (1) strong associations between psychiatric comorbidity and CHD in Brazil, (2) associations for MDD and GAD, in addition to MADD and the comorbid group, with angina (without a history of MI or revascularisation), emphasizing the need for close monitoring of these individuals to avoid further adverse events, and (3) that psychiatric comorbidity is associated with MI and coronary revascularization.

The most robust associations with CHD were observed in those individuals with psychiatric comorbidity. It is worth noting here that the combined presence of anxious and depressive symptoms is associated with more than a twofold increased risk of mortality in patients with ischemic heart disease ([@B9]), relative to those who were free from psychiatric symptoms. We have previously shown that reduced heart rate variability -- a predictor of future mortality -- is most reduced in MDD patients with GAD ([@B16]), demonstrating the adverse effects of distinctive clinical features including a depressive episode, persistent worry, and hypervigilance on cardiac function (see also [@B14]). In the present study, we also observed that only disorders with concurrent anxiety and depression (comorbid MDD and anxiety, and MADD) also displayed associations with 'hard' CHD endpoints including MI and coronary revascularisation. While our findings are consistent with studies from high-income countries (e.g., [@B33]), highlighting greater associations with comorbid anxiety and depression, our study also highlights associations with CHD in participants without psychiatric comorbidity. In particular, we observed associations between MDD and GAD, and CHD, further highlighting the importance of non-comorbid, chronic depression, and generalized anxiety, rather than disorders involving heightened phasic anxiety (the phobias and panic disorder). These findings further suggest that characteristic features of depression (anhedonia), generalized anxiety (anxious apprehension), and psychiatric comorbidity (trait negative affect) may all contribute to the associations we observed here in Brazil.

Prior research has indicated that Brazil is a country where depression (and presumably anxiety) is most often somaticized ([@B28]; see also [@B20]). While this suggests that the associations we observed here may in part, reflect an overlap of somatic symptoms observed in mental illness and physical disease, the importance of this finding should not be minimized. Prognosis for patients with angina is not benign; in fact, it is no better than those with MI and/or revascularization (e.g., [@B4]). Some limitations of this study are worth noting here. These include the cross-sectional design of the study, generalizability of the sample beyond civil servants in Brazil, and the possibility of undetected or undiagnosed CHD considering that classification of CHD was based on self-report. The cross-sectional design of the study makes it impossible to determine whether the mood and anxiety disorders preceded CHD or vice versa. That said, the literature suggests that the relationship between MDD (and anxiety) and CHD is bidirectional and reciprocal ([@B21]; [@B23]; [@B30]). We also note that the ELSA-Brasil cohort captures the racial, social, and regional diversity in the Brazilian population (see [@B27]), highlighting the relevance of the present study's findings for developing countries. It is possible, however, that non-diagnosed CHD is *lower in our sample*, than for the general Brazilian population, as the civil servants who participated in our study have more access to health services. It is possible therefore that the associations we observe here are lower than those that might be observed in the general Brazilian population. Indeed, it has been noted previously that there is a low identification rate for depression and other CMDs in Brazil ([@B20]; see also [@B19]; [@B5]).

There are a number of potential explanations for the associations we observed between the CMD (and specific diagnostic groupings) and CHD including psychosocial and biological factors. Brazil currently faces major social challenges, which may contribute to chronic stress and increased morbidity ([@B8]), strengthening the associations between mental disorders and CHD we observed here, in comparison to high-income countries. In addition to income inequality ([@B11]), personal safety remains an issue of great concern. For example, findings from a representative sample of 15 to 75-year old residents of São Paulo and Rio de Janeiro in Brazil indicated that psychiatric disorders and traumatic events, especially violence, are extremely common ([@B25]). Nearly 90% of participants surveyed in that study faced a lifetime exposure to actual or threatened death, and these traumatic events correlated with all psychiatric diagnoses. These results are particularly relevant in light of other research ([@B26]) highlighting a dose-response association between psychological distress and increased risk of mortality from a variety of causes including CVD, cancer and external causes over 8 years. Biological factors may also underpin associations between the mood and anxiety disorders and CHD including autonomic dysfunction, a hyperactive hypothalamic-pituitary-adrenal axis, increased activity in the sympatho-adreno-medullary activity, increased inflammation, and platelet activation and aggregation ([@B21]; [@B23]; [@B30]; [@B18]). Decreases in heart rate variability indicative of autonomic dysfunction may provide a structural link between emotional disturbance and failure to appropriately regulate inflammatory processes leading to increased morbidity and mortality from a host of disorders including CVD's ([@B15]). Disturbances in the immune system may also lead to depression ([@B7]), highlighting the bidirectional relationships between the mental disorders, and physical disease.

Our study is characterized by a number of strengths including a focus on a relatively large and well-characterized sample of the Brazilian population, consideration of a variety of specific mood and anxiety disorder groupings, application of a structured clinical interview -- rather than self-report -- to determine psychiatric diagnoses, and adjustment for a host of covariates known to contribute to metabolic and cardiovascular risk. Recently, we reported that that use of tricyclic antidepressants is associated with a twofold increase in prevalent CHD, above and beyond severity of mood and anxiety symptoms ([@B13]). Importantly, we demonstrate here that the association between mood and anxiety disorders, and CHD is above and beyond use of antidepressant medications including tricyclic antidepressants. A recent statement by the Canadian Network for Mood and Anxiety Treatments (CANMAT) task force ([@B24]) highlights the bidirectional relationship between the mood and anxiety disorders, and a variety of medical conditions including cardiovascular disease, cerebrovascular disease, cancer, human immuno-deficiency virus, hepatitis C virus, migraine, multiple sclerosis, epilepsy, and osteoporosis. Given the increased risks for morbidity and mortality associated with comorbid psychiatric and medical conditions, future studies are needed to better understand the pathways underpinning their comorbidity, with a goal toward developing more effective preventive strategies and treatments. Interested readers are referred to recent guidelines for pharmacological and psychosocial management in low and middle-income countries ([@B20]). In conclusion, the present study provides important new information on the association between the mental disorders and CHD in Brazil. Findings indicate that the most robust association with CHD relates to symptomatic and diagnostic, psychiatric comorbidity, although an association with MDD and GAD was also observed. Both MDD and GAD were found to be associated with an increase in the odds for CHD overall as well as angina pectoris, which may have adverse implications for the future health of ELSA-Brasil participants. Considering that comorbid psychiatric illness and CHD is associated with increased morbidity and mortality ([@B18]), findings reinforce a need for, and the importance of, comprehensive health assessment in Brazil, a country that faces major social challenges and inequities.
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